Reid Hoffman Raises 246 Million for AI CancerResearch Startup Manas AI Amadeus Fire AG Shareholders Overwhelmingly Approve All Agenda Items Including New Authorised Capital 2026 AI Stocks Plunge as Chinas DeepSeek Sparks Broad Market Rout Analyst Sentiment on JB Hunt Transport Stock in Focus Microsoft Appoints Accessibility Veteran to Lead Responsible AI Development Amid Speed vs Safety Tensions 401k Millionaire Count Declines but Record Savings Rates Signal LongTerm Optimism BUR Q1 2026 Earnings Massive EPS Miss Sends Shares Lower RadNet Inc RDNT Q1 2026 Earnings EPS Misses Estimates Amid Disappointing Quarter IZEA Q4 2025 Earnings EPS Misses Estimates Stock Rises in AfterHours Trading HOVR Q1 2026 Earnings WiderThanExpected Loss as Development Continues Stock Surges Over 26 German American Bancorp GABC Q1 2026 Earnings EPS Misses Estimates Amid Stable Operating Environment GTN Q1 2026 Earnings EPS Misses Estimates as Media Headwinds Persist Cipher Digital Inc CIFR Ascends 209 as Momentum Builds Toward Key Resistance Zone Bath Body Works BBWI Holds Steady Near 1773 as Traders Eye Key Support and Resistance Levels Abundia Global Impact Group AGIG Surges 446 Testing Resistance at 123 KF Growth Acquisition Corp II KFII Holds Steady Near Resistance as SPAC Sector Waits for Catalyst DigitalBridge Group DBRG Holds Steady Near Support as Volume Signals Caution SpaceXs Potential SP Sector Classification A Multifaceted Challenge HBT Q1 2026 Earnings EPS Misses Estimates by 4481 as Net Income Falls Short Nexstar Media Group NXST Holds Steady Near 189 as Traders Eye Key Resistance Zone Playtika PLTK Holds Near Key Support Amid Flat Trading Session Corbus Pharmaceuticals CRBP Slides 14 as Key Support Level Comes into Focus iSpecimen ISPC Shows Resilience Up 59 as Buyers Defend Key Support Pelthos Therapeutics Inc PTHS Declines 263 as Stock Tests Key Support Levels ONE Gas OGS Holds Steady Near Support as Natural Gas Sector Shows Resilience John Hancock Income Securities Trust JHS Holds Steady at 1102 Amid RangeBound Trading Denali Therapeutics DNLI Gains 387 as Stock Nears Key Resistance Level